Competition And Antitrust Laws Sweeping Asia Create New Hurdles For MNCs
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - The emergence and evolution of competition and antitrust regimes across Asia could create new hurdles for multinational pharmaceutical companies that control large swaths of a particular market or are looking to expand through mergers and acquisitions